Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katie Moore
N348I in HIV-1 Reverse Transcriptase Decreases Susceptibility to Tenofovir and Etravirine in Combination With Other Resistance Mutations
AIDS
Infectious Diseases
Allergy
Immunology
Related publications
Connection Domain Mutations in HIV-1 Reverse Transcriptase Do Not Impact Etravirine Susceptibility and Virologic Responses to Etravirine-Containing Regimens
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Selection of Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutations in HIV-1 Subtype C: Evidence of Etravirine Cross-Resistance
AIDS
Infectious Diseases
Allergy
Immunology
Connection Domain Mutations N348I and A360V in HIV-1 Reverse Transcriptase Enhance Resistance to 3′-Azido-3′-Deoxythymidine Through Both RNase H-Dependent and -Independent Mechanisms
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Quantum Chemical Study of Molecular Recognition Between Etravirine/Rilpivirine and the HIV-1 Reverse Transcriptase
Madridge Journal of Novel Drug Research
Mutations in the Connection Domain of HIV-1 Reverse Transcriptase Increase 3'-Azido-3'-Deoxythymidine Resistance
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Combination of Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Required for Resistance to the Carbocyclic Nucleoside 1592U89.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Anti-Hiv Drugs and Resistance: Inhibitors of HIV-1 Reverse Transcriptase and Protease
Pharmacokinetics of Etravirine Combined With Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients
AIDS Research and Treatment
Immunology
Public Health
Allergy
Environmental
Dermatology
Infectious Diseases
Occupational Health
